Poster Presentation – American Epilepsy Society (AES) 2022

Our partner, Dante Labs, presented work from our collaboration on genetic epilepsies at the American Epilepsy Society (AES) meeting in December 2022. In this study, BioSymetrics analyzed genetic datat from patients with different epilepsy phenotypes and identified novel gene-disease relationships for phenoclusters of patients.

Phenotype-driven identification of drug targets for post-COVID-19 anosmia

Discriminating Acute Respiratory Distress Syndrome from other forms of respiratory failure via itera

$\setCounter{0}$

Poster Presentation – American Epilepsy Society (AES) 2022

Phenotype-driven identification of drug targets for post-COVID-19 anosmia

Discriminating Acute Respiratory Distress Syndrome from other forms of respiratory failure via itera

BioSymetrics﻿

BioSymetrics